Clinical Trial Update: Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on aminolevulinic acid photodynamic therapy for cervical persistent high-risk HPV infection and cervical intraepithelial neoplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Cervical Persistent High-risk Hpv Infection

Drugs mentioned

• aminolevulinic acid photodynamic therapy (aminolevulinic acid photodynamic therapy)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Cervical Persistent High Risk HPV Infection, Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED